GI Drugs Flashcards
Omeprazole
Proton pump inhibitor
MOA: irreversibly inhibits H/K ATPase in stomach parietal cells
USES: peptic ulcer, gastritis, esophageal reflux, Zollinger-Ellison syndrome
TOXICITY: increased risk of C. Difficile infection, pneumonia. Hip fractures, decreased serum mg++ with long term use
Cimetidine
MOA: reversible inhibitor of histamine binding H2 receptor leading to decreased secretion of acid by parietal cells
USES: peptic ulcer, gastritis, mild esophageal reflux
TOXICITY: potent inhibitor of CYP450 which increases levels of drugs metabolized by CYPS; also has anti-androgenic effects (prolactin release, gynecomastia, impotence, decreased libido in males); can cross BBB (confusion, dizziness, headaches) and placenta. Both cimetidine and ranitidine decrease renal excretion of creatinine. Other H2 blockers are relatively free of these effects.
Misoprostol
MOA: PGE1 analog. increases production and secretion of gastric mucous barrier and decreases acid production
USES: prevention of NSAID-induced peptic ulcers (NSAIDs block PGE1 production); Maitenance of a PDA. Also used to induce labor (ripens cervix).
TOXICITY: diarrhea. Contraindicated in women of childbearing potential (abortificant)
Metoclopramide
MOA: D2 receptor antagonist. Increases resting tone, contractility, LES tone, motility. Does not influence colon transport time.
USES: diabetic and post-surgery gastroparesis; IV form as antiemetic
TOXICITY: Parkinsonian effects. Restlessness, drowsiness, fatigue, depression, nausea, diarrhea. Drug interaction with digoxin and diabetic agents. Contraindicated in patients with small bowel obstruction or Parkinsonian disease (D1-receptor blockade)
Sulfasalazine
MOA: a combination of sulfapyridine (antibacterial) and 5-aminosalicyclic acid (anti-inflammatory). Activated by colonic bacteria
USES: mild ulcerative colitis, Crohn’s disease
TOXICITY: Malaise, nausea, sulfonamide toxicity, reversible oligospermia
Ondansetron
MOA: 5-HT3 antagonist (antiemetic) decreases vagal stimulation; blocks binding of serotonin that initiates vomit reflex
USES: control vomiting postoperatively and in patients undergoing chemo
TOXICITY: headache, constipation
Scopolamine
Belladonna alkaloid
MOA: muscarinic receptor antagonist
PK: metered 3-day dose; percutaneous absorption, patch must be placed behind ear
USES: prevention of nausea and vomiting associated with motion sickness and recovery from anesthesia and surgery
TOXICITY: dry mouth, drowsiness
Ranitidine
MOA: reversible inhibitor of histamine binding H2 receptor leading to decreased secretion of acid by parietal cells
USES: peptic ulcer, gastritis, mild esophageal reflux
TOXICITY: Both cimetidine and ranitidine decrease renal excretion of creatinine. Other H2 blockers are relatively free of these effects.
Famotidine
MOA: reversible inhibitor of histamine binding H2 receptor leading to decreased secretion of acid by parietal cells
USES: peptic ulcer, gastritis, mild esophageal reflux
Nizatidine
MOA: reversible inhibitor of histamine binding H2 receptor leading to decreased secretion of acid by parietal cells
USES: peptic ulcer, gastritis, mild esophageal reflux
Lansoprazole
Proton pump inhibitor
MOA: irreversibly inhibits H/K ATPase in stomach parietal cells
USES: peptic ulcer, gastritis, esophageal reflux, Zollinger-Ellison syndrome
TOXICITY: increased risk of C. Difficile infection, pneumonia. Hip fractures, decreased serum mg++ with long term use
Esomeprazole
Proton pump inhibitor
MOA: irreversibly inhibits H/K ATPase in stomach parietal cells
USES: peptic ulcer, gastritis, esophageal reflux, Zollinger-Ellison syndrome
TOXICITY: increased risk of C. Difficile infection, pneumonia. Hip fractures, decreased serum mg++ with long term use
Pantoprazole
Proton pump inhibitor
MOA: irreversibly inhibits H/K ATPase in stomach parietal cells
USES: peptic ulcer, gastritis, esophageal reflux, Zollinger-Ellison syndrome
TOXICITY: increased risk of C. Difficile infection, pneumonia. Hip fractures, decreased serum mg++ with long term use
Dexlansoprazole
Proton pump inhibitor
MOA: irreversibly inhibits H/K ATPase in stomach parietal cells
USES: peptic ulcer, gastritis, esophageal reflux, Zollinger-Ellison syndrome
TOXICITY: increased risk of C. Difficile infection, pneumonia. Hip fractures, decreased serum mg++ with long term use
Bismuth
MOA a: bind to ulcer base, providing physical protection and allowing bicarbonate secretion to reestablish pH Gradient in the mucous layer
USES: increase ulcer healing, travelers diarrhea